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Results

Overall Mortality Rate and Reasons for Death
Outof90patients,41diedontheICU(overallICUmortality rate45.6%).SepsiswasthemainreasonfordeathontheICU (n = 20/41; 48.8%). Within this group, the source of infection waspneumoniain14cases(70%ofsepsiscases).6patientshad a different site of infection or pneumonia and an additional focus,orthefocusremainedunclear(30%ofsepsiscases).
Introduction
Admissionofpatientswithahematologicalmalignancy(HM) on an intensive care unit (ICU) is subject to controversial discussion.Lifeexpectancyofthesepatientsisoftenreduced duetotheunderlyingmalignantdisease.Basedontheunderlyingdiseaseandthesubsequentchemotherapy,theytypically developinfectiouscomplicationsafteradmissiontotheICU. Intheliterature,respiratoryfailure(41-45%)andsepsis(24-33%) were the main reasons for an ICU admission and the ICUmortalityrankedbetween30and69%inthesepatients [1] [2] [3] . Nevertheless, an ICU stay may bridge a transitory complication and thus donate lifetime even to patients with advancedmalignantdiseases.
Although the overall ICU mortality in this collective is high, it does not seem to be correlated with the underlying HM. Comparable to patients without malignant disease, the outcome of these patients was adversely influenced by high pointsinvariousscoresassessingorganfailure,hemodynamic instability, and mechanical ventilation as parameters for the severity of the disease leading to ICU admission. Type and activityoftheHM,recentchemotherapyorneutropeniadid notconstituteindependentriskfactorsforICUmortality [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] . Only bone marrow transplantation or peripheral blood stem cell transplantation (PBSCT) were associated with a worseoutcomeontheICU,withamortalityashighas2/3 [8, 9] .ThedecisionfororagainstanICUadmissionofpatients withhemato-oncologicaldiseasesbecomesincreasinglyindependentoftheunderlyingmalignantdisease.Therefore,cancerpatientsshouldnotbeexcludedfromreferraltotheICU inanemergencysolelyduetotheirunderlyingmalignantdiseaseorasingleunfavorableprognosticfactor [11] .Morerisk factorsforanadverseoutcomeinthispatientgroupneedto be defined to direct the ICU clinicians toward an early and effectivetreatment.Abetterunderstandingoffactorsthatpotentially influence the patient outcome can help healthcare professionalsmakeappropriatemanagementdecisions.
Therefore,weevaluatedthecharacteristicsandoutcomes of patients to identify risk factors for adverse outcome with HMsrequiringintensivecare.
Patients and Methods
From November 2005 until November 2006, 90 adult patients with HM who were transferred to a 10-bed, noncardiological medical ICU at the University Hospital Munich were retrospectively evaluated. The study protocol was approved by the institutional data protection committee. Lackinganyinterventions,informedconsentwaswaived.
Thevariablesage,gender,typeofHM,typeofICUadmissiondiagnosis,lengthofICUstay,simplifiedacutephysiologyscore(SAPS)IIonadmissiontotheICU,leukocytecountonadmissiontotheICU,maximum amountofcatecholaminesrequired,renalfailuredefinedasneedforhemodialysisorhemofiltration,andneedforinvasiverespiratorysupportwere analyzedretrospectivelywithregardtotheirinfluenceonICUandday-100 mortality [11] .Thebaselinecharacteristicsaresummarizedintable1. 
Variables without Statistically Significant Influence on ICU and/or Day-100 Mortality Age and Gender
There was no significant influence of age or gender of the atientsonthemortality.
Underlying Hematological Disease
Acute myeloid leukemia was the most common diagnosis (n=25;27.8%),followedbyhigh-gradenon-Hodgkin'slymphoma(NHL;n=18;20.0%)andmultiplemyeloma(n=13; 14.4%).Othermalignanciesincluded:low-gradeNHL(n=8; 8.9%), acute lymphatic leukemia (AML; n = 7; 7.8%), Hodgkin'slymphoma(n=6;6.7%),myelodysplasticsyndrome (MDS;n=5;5.5%),chronicmyeloidleukemia(n=4;4.4%), chroniclymphaticleukemia(n=2;2.2%),andnon-malignant hematologicaldiseases(n=2;2.2%).Comparingtheoutcome oftheleukemias(n=43,47.8%)tothelymphomas(n=45, 50%)yieldednosignificantdifferenceintermsofmortality.
Analyzing the ICU and day-100 mortality of subgroups compared to patients with AML yielded no statistically significant differences for patients with high-grade lymphomas, multiplemyelomas,low-gradelymphomas,andMDS.Neverthelesstherewasatrendtowardsabetteroutcomeinpatients withlow-gradelymphomas,andatrendtowardsaworseoutcomeinthosewithMDS.
Leukocyte Count
Mortality was not significantly influenced by leukopenia of anyextent.
Mechanical Ventilation
Patients needing mechanical ventilation had a significantly higher ICU and day-100 mortality by univariate analysis (p < 0.0001 and p = 0.0059, respectively), but the variable failed to show significant influence on the mortality in the multivariateregressionanalysis.
Detailedinformationisgivenintables2-4.
Discussion
Generally,cancerpatientsareathighrisktoberefusedbythe ICU. With good reason, oncologists and intensivists reserve ICU admission for select cancer patients with potentially reversible medical conditions and a reasonable prospect of substantialrecovery [12] .Moreover,thereisgrowingevidence that the mortality of patients with HM during or after their stayontheICUdoesnotdependonfactorsassociatedwith themalignancy [13] .Maschmeyerandco-authorsreportedon a retrospective outcome analysis of 189 consecutive cancer patientsreferredtotheICUasemergenciesduringa2-year period. They identified sepsis, mechanical ventilation, vasopressorsupport,renalreplacementtherapy,andneutropenia as independent risk factors for fatal outcome. But restrictively,nosinglefactorunequivocallypredicteddeath [13] . Horster/Stemmler/Mandel/Mück/ Tischer/Hausmann/Parhofer/Geiger differencesintheoutcomeofsubgroupsarerestrictedbylow patientnumbers. InaccordancewiththefindingsofMaschmeyeretal. [13] , withmultivariateregressionanalysis,wefoundtheICUand/or day-100mortalitytobesignificantlyassociatedwiththereason for ICU admission, like sepsis and acute respiratory failure, andwithparametersforacuteillness,namelyahighSAPSII, highdosesofcatecholamines,renalreplacementtherapy,and lengthofICUstay.Patientsadmittedforpost-interventional carehadasignificantlybettersurvivalthan patientsadmitted foracutemedicalillness,probablyduetoaselectionbiasbeforesurgicalinterventionandaprophylacticICUadmissionin some cases of post-interventional observation. Additionally, thedurationoftheICUstaywasapredictorforhighermortalitywithanincreaseinmortalityof5%perday,althoughsome patients deceased within a few days on the ICU with severe gram-negativesepsis,pointingouttheimportanceofthisvariable. As others have shown before, leukopenia and type of HM did not generally influence the patient outcome [1] [2] [3] [4] [5] . EveninthestudyofMaschmeyeretal. [13] ,neutropeniaasa singleriskfactorunequivocallypredicteddeath.
Comparabletopatientswithoutmalignantdisease,respiratoryfailure(41-45%)andsepsis(24-33%)weremajorreasons forICUadmissioninthispatientsgroup.Theiroutcomewas adverselyinfluencedbyhighpointsindifferentscores assessing organfailure,hemodynamicinstability,andmechanicalventilationasparametersfortheseverityofthediseasethatfinally leadstoICUadmission.Similarlytopatientswithoutcancer, mortalityrankedbetween30and69%inthese patients [1] [2] [3] [4] [5] [6] [7] [8] .
These findings need to be pointed out as the fatality of malignant diseases perceived by physicians still exceeds the expected mortality [14] . To contribute to the discussion concerningICUadmissionofHMpatients,weretrospectively analyzeddatafrom90patientsadmittedtothemedicalICUof theuniversityhospitalinMunich,Germany,over13months.
Certainly,thepresentdataareaffectedbyseveralfactors: Thestudyrepresentsdatafromasinglecenter,andthesedata were collected retrospectively. Moreover, the study reflects thedecisionofasinglecenterfororagainstICUadmission, bearingthepotentialriskofapre-ICUselectionbias.Wedid not analyze patients with very advanced malignancies who were not referred to the ICU. Finally, statements regarding ICUadmissionofthesepatients.Fuetal.,however,analyzed thesurvivalofpatientswithmetastaticcancer(MC)requiring ICU admission and observed disastrous survival times for patients needing medical ICU care (2.5 weeks), mechanical ventilation (6 days) and cardio-pulmonary resuscitation (CPR;1day).Contrarily,theyobservedbettersurvivaltimes in patients requiring ICU observation after post-surgical intervention alone (21.5 weeks), probably due to a selection biasbeforesurgicalinterventionandaprophylacticadmission diagnosistotheICUinsomecases.Ontheotherhand,itwas noted that patients who required ICU admission for postsurgery/interventional care, and even a small portion of patientswhowereadmittedtotheICUfornonsurgicalreasons, survivedformorethan1year [14] .
Similarlytothesefindings,thepresentstudyshowedthat not only the severity of the acute illness but also the reason for ICU admission determined the survival of patients with HM.Althoughtheunderlyingmalignancylosessomeimportanceinthissetting,optimismconcerningthesurvivalofthese patientsafterICUadmissionseemstobeoutofplace.Itmay be reasonable to consider ICU admission in cancer patients independently of the underlying malignancy for post-interventionalcareandtodiscussadmissionforotherreasonson anindividualbasiswiththepatientsandtheirfamilies.
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Thedivisionintogroupslike'leukemia'and'lymphoma'is rather rough and may not serve well to clarify whether the typeofHMinfluencesmortality.Clearly,wefounddifferent mortalityrateswithinsubgroups,withatrendtowardsabetter outcome of patients with low-grade lymphomas and a worseoutcomeofthosewithMDS.Buttheinterpretationof thesefindingsishamperedbytheremaininglowpatientnumbers within these subgroups. A division into more precisely defineddiseasegroups,alongwithanalysesofothervariables concerning the HM, e.g. disease stage or previous chemotherapy,shouldbemadewithlargerpatientgroupstoaddress thisquestion.Despitethebroadagerangeofthepatientsin theexistingpatientgroup(mean56years,range21-85years), agedidnotsignificantlyinfluencetheoutcome.Thiswascontrarilyobservedinotherstudies,whichhaveshownanassociation of older age and mortality [9] . Although mechanical ventilationisanindicatorforsevererespiratoryfailureanda procedureconstitutingariskfactoronitsown,thenecessity ofmechanicalventilationsignificantlyinfluencedtheoutcome only in the univariate analysis. This is probably due to the smallpatientgroupanalyzedforitsinterconnectionwiththe variable'acuterespiratoryfailure',apatientgroupwithhigh mortality, as well as with the variable 'post-interventional observation' with low mortality. Indeed, another study confirmed that ICU mortality was lower in post-surgical cancer patients,evenwhentheyrequiredmechanicalventilation [15] .
FarfromquestioningICUadmissionofpatientswithHM, Hampshire et al. [6] found the hospital mortality of HM patientstobeassociatedwithalonghospitalstaybeforeICU admissionandseveresepsis;thissuggestsconsideringanearly
